The new skeletally stabilized dichlorotriphosphazanes C6H4N2(PhPCl)2PPh (5) and C6H4N2(MePCl)2PMe (6) have
been prepared from reactions between PhPCl2 or MePCl2 and 1,2-(NH2)2C6H4 or 1,2-(Me3SiNH)2C6H4, respectively.
Reaction of PhPCl2 with the phosphadiazole C2H4(Me3SiN)2PPh yields triphosphazane C2H4N2(PhPCl)2PPh (8).
Compounds 5, 6, and 8 form as mixtures of three diastereomers; characterization is based on spectral data and
derivatization of 5 and 8 to the amino and thio(amino) triphosphazanes C6H4N2[PhP(NHiPr)]2PPh (7) and
C2H4N2[PhP(S)NEt2]2PPh (10). The 31P NMR spectra of 5 and 6 in solution have been measured as a function
of temperature and solvent donor and dielectric strength. The solution properties of the dichlorotriphosphazanes
and the implications of these on subsequent reaction chemistry are discussed.
Skeletal P-N-P unit conformational preferences of the unsymmetrically substituted bis(phosphino)amines erythro-¡-PrN[PhP(i-PrNH)][PhP(EtNH)] (4A), meso-and ¿,/-z-PrN[PhP(¡-PrNH)]2 (5A and SB), erythro-i--[PhP(z'-PrNH)] [PhP(z-BuNH)] ( 6), eryZAro-z-PrN[PhP(z-PrNH)][PhP(PhNH)] (7), and eryfAro-i-PrN[PhP-(PhNH)]2 (8) have been examined. Compound 8, newly prepared in this study, and the previously synthesized 4A and 5A have been characterized by X-ray single-crystal analysis: 4A, monoclinic, Pl\/n, a = 10.678(4) A, b =
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.